; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (157) Fluoxastrobin formulations Heading 9902.09.41 is amended— (A) by amending the article description to read as follows: Product mixtures containing (E)-{2-[6-(2-chlorophenoxy)-5-fluoropyrimidin-4-yloxy] phenyl} (5,6-dihydro-1,4,2-dioxazin-3-yl) methanone O-methyloxime (Fluoxastrobin) (CAS No. 361377–29–9) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (158) Fluopyram and tebuconazole formulations Heading 9902.09.48 is amended— (A) by amending the article description to read as follows: Product mixtures containing N-{2-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]ethyl}-2-(trifluoromethyl) benzamide (Fluopyram) (CAS No. 658066–35–4) and 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl) pentan-3-ol (Tebuconazole) (CAS No. 107534–96–3) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (159) Trifloxystrobin and tebuconazole formulations Heading 9902.09.53 is amended— (A) by amending the article description to read as follows: Product mixtures containing methyl (E)-methoxyimino-{(E)-2-[1-(α,α,α-trifluoro-m-tolyl) ethylideneaminooxy]-o-tolyl}acetate (Trifloxystrobin) (CAS No. 141517–21–7) and (RS)-1-p-chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl) pentan-3-ol (Tebuconazole) (CAS No. 107534–96–3) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (160) Fluopyram + pyrimethanil formulations Heading 9902.09.54 is amended— (A) by amending the article description to read as follows: Product mixtures containing N-[2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl]-2-(trifluoromethyl) benzamide (Fluopyram) (CAS No. 658066–35–4) and 4,6-dimethyl-N-phenyl-2-pyrimidinamine (Pyrimethanil) (CAS No. 53112–28–0) (provided for in subheading 3808.92.15)